Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
COSCIENS Biopharma (CSCI)
NASDAQ:CSCI
Holding CSCI?
Track your performance easily
CSCI Stock Chart & Stats
Day’s Range― - ―
52-Week Range$2.50 - $11.10
Previous Close$3.43
Volume4.98K
Average Volume (3M)7.46K
Market Cap
$9.91M
Enterprise Value-$9.21M
Total Cash (Recent Filing)$22.00M
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.55
Next Earnings
Apr 01, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-26.09
Shares Outstanding3,123,513
10 Day Avg. Volume13,157
30 Day Avg. Volume7,455
Standard Deviation0.24
R-Squared0.11
Alpha-0.05
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.75
Price to Cash Flow (P/CF)-0.20
P/FCF Ratio0.00
Enterprise Value/Market Cap-0.93
Enterprise Value/Revenue-2.12
Enterprise Value/Gross Profit-2.05
Enterprise Value/Ebitda0.50
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
COSCIENS Biopharma News
PremiumCompany Announcements
COSCIENS Biopharma Focuses on Natural Product Growth
PremiumCompany Announcements
COSCIENS Biopharma Advances Merger and Pipeline
PremiumCompany Announcements
COSCIENS Biopharma Restructures Board After Resignation
PremiumCompany Announcements
COSCIENS Biopharma Welcomes New Board DirectorPremiumCompany Announcements
COSCIENS Biopharma Advances Merger and Seeks New LeadershipOwnership Overview
1.50%
Insiders
0.03% Mutual Funds
<0.01% Other Institutional Investors
98.47% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
CSCI FAQ
What was COSCIENS Biopharma’s price range in the past 12 months?
COSCIENS Biopharma lowest stock price was $2.50 and its highest was $11.10 in the past 12 months.
What is COSCIENS Biopharma’s market cap?
COSCIENS Biopharma’s market cap is $9.91M.
When is COSCIENS Biopharma’s upcoming earnings report date?
COSCIENS Biopharma’s upcoming earnings report date is Apr 01, 2025 which is in 73 days.
How were COSCIENS Biopharma’s earnings last quarter?
COSCIENS Biopharma released its earnings results on Nov 12, 2024. The company reported -$1.85 earnings per share for the quarter, missing the consensus estimate of N/A by -$1.85.
Is COSCIENS Biopharma overvalued?
According to Wall Street analysts COSCIENS Biopharma’s price is currently Overvalued.
Does COSCIENS Biopharma pay dividends?
COSCIENS Biopharma does not currently pay dividends.
What is COSCIENS Biopharma’s EPS estimate?
COSCIENS Biopharma’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does COSCIENS Biopharma have?
COSCIENS Biopharma has 3,123,513 shares outstanding.
What happened to COSCIENS Biopharma’s price movement after its last earnings report?
COSCIENS Biopharma reported an EPS of -$1.85 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -10.18%.
Which hedge fund is a major shareholder of COSCIENS Biopharma?
Currently, no hedge funds are holding shares in CSCI
---
Company Description
COSCIENS Biopharma
Æterna Zentaris, Inc. operates as a specialty biopharmaceutical company that is engaged in developing and commercializing novel treatments in oncology, endocrinology and women's health. It operates through biopharmaceutical segment. AEterna Zentaris was founded on September 12, 1990 and is headquartered in Charleston, SC.
---
Technical Analysis
Amgen
―
Gilead Sciences
―
Biogen
―
Regeneron
―
Vertex Pharmaceuticals
―
Bio-Path Holdings
―
---